EC-0652 Uses, Dosage, Side Effects and more
EC-0652 is under investigation in clinical trial NCT02202447 (Phase 1 of EC1169 In Patients With Recurrent MCRPC).
| Attribute | Details |
|---|---|
| Trade Name | EC-0652 |
| Generic | EC-0652 |
| Type | |
| Formula | C47H65N9O17S |
| Weight | Average: 1060.14 Monoisotopic: 1059.421912843 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Innovators Monograph
Search Medicines
